new glp 1 agonist novo nordisk glp-1 receptor medications Today, we approved the first generic for an injectable Novo Nordisk: A New Boost
Description
Let's hope it helps decrease the cost of treatment and make this treatment option available to a wider population
2013;36(2):S245S252
doi: 10.1111/dom.12076
And that brings us to the next issuehealth care costs
However, since STR activation has been reported to upregulate SGLT1 expression [44, 48], it is possible that chronic STR activation may affect GIP secretion via SGLT1 upregulation
Obesity therapeutics are entering an era in which targeting multiple receptors, rather than fewer, may produce superior outcomes, but the chemistry must evolve to keep pace
